Evolus Shares Up 17% on Q4, Full Year Earnings

Evolus Inc. jumped 17% in after-hours trading today after reporting fourth quarter and full year earnings. 

The Newport Beach-based aesthetics company had revenue of $90.3 million for the fourth quarter and $297.2 million for the full year. 

“In 2025 we generated nearly $300 million in total net revenue delivering our sixth consecutive year of double-digit growth,” Chief Executive David Moatazedi said in a statement. 

Moatazedi said that the company expects to deliver on its 2026 revenue guidance of $327 million to $337 million with “core commercial infrastructure now in place.” 

Upcoming milestones for the company include anticipated U.S. approval of Evolysse Sculpt in the fourth quarter of this year and the commercial launch of Estyme in Europe.